Rakovina Therapeutics Inc. (RKV:TSXV) closed at $0.220 on October 16, 2026, unchanged on the day. The stock trades 31.3% below its 52-week high of $0.320 and 158.8% above its 52-week low of $0.085. Over the past year, it lost 12.0%. Rakovina Therapeutics Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| 0.00% | -10.20% | +69.23% | +120.00% | -12.00% |
In 252 trading sessions since October 16, 2025, RKV closed higher on 87 days (35%). Its best day was September 8, 2026 (+45.45%) and its worst was March 30, 2026 (-25.00%). The stock moved 10% or more in a single session 43 times. It opened at least 5% above the previous day's high 28 times.
Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some f its products in the pipeline include kt-2000 Next Generation PARP-inhibitors, kt-3000 Dual Action DDR-inhibitors, and kt-4000 DNA Damaging DDR-inhibitors.
Find more stocks like RKV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.